Antimicrobial Resistance and Mortality in Hospitalized Patients with Bacteremia in the Greater Paris Area from 2016 to 2019

References

• Antimicrobial resistance in the EU/EEA (EARS-Net). Annual epidemiological report for 2019. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/surveillance-antimicrobial-resistance-Europe-2019.pdf. Accessed December 8, 2022.
   Google Scholar
• Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Opatowski M, Tuppin P, Cosker K, et al. Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016. Epidemiol Infect. 2019;147:e144. doi:10.1017/S0950268819000402
   Web of Science ®Google Scholar
• Wang XQ, Vincent BM, Wiitala WL, et al. Veterans Affairs patient database (VAPD 2014–2017): building nationwide granular data for clinical discovery. BMC Med Res Methodol. 2019;19(1):94. doi:10.1186/s12874-019-0740-x
   Web of Science ®Google Scholar
• Jannot AS, Zapletal E, Avillach P, Mamzer MF, Burgun A, Degoulet P. The Georges Pompidou University Hospital Clinical Data Warehouse: a 8-years follow-up experience. Int J Med Inform. 2017;102:21–28. doi:10.1016/j.ijmedinf.2017.02.006
   Web of Science ®Google Scholar
• Khalaf Hamoud A, Salah Hashim A, Akeel Awadh W. Clinical data warehouse a review. IJCI. 2018;44(2). doi:10.25195/2017/4424
   Google Scholar
• McDanel JS, Roghmann MC, Perencevich EN, et al. Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study. Clin Infect Dis. 2017;65(1):100–106. doi:10.1093/cid/cix287
   PubMed Web of Science ®Google Scholar
• Hoertel N, Sánchez-Rico M, Vernet R, et al. Observational study of haloperidol in hospitalized patients with COVID-19. PLoS One. 2021;16(2):e0247122. doi:10.1371/journal.pone.0247122
   PubMed Web of Science ®Google Scholar
• Kramer J, Hartman C, White D, et al. Validation of HIV ‐infected cohort identification using automated clinical data in the Department of Veterans Affairs. HIV Med. 2019:hiv.12757. doi:10.1111/hiv.12757
   Web of Science ®Google Scholar
• Daniel C, Serre P, Orlova N, Bréant S, Paris N, Griffon N. Initializing a hospital-wide data quality program. The AP-HP experience. Comput Methods Programs Biomed. 2019;181:104804. doi:10.1016/j.cmpb.2018.10.016
   Web of Science ®Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682. doi:10.1093/aje/kwq433
   PubMed Web of Science ®Google Scholar
• Annual Health Facilities Statistics (Statistique annuelle des établissements de santé). Available from: https://www.sae-diffusion.sante.gouv.fr/sae-diffusion/recherche.htm. Accessed December 8, 2022.
   Google Scholar
• Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24(4):584–602. doi:10.1093/clind/24.4.584
   PubMed Web of Science ®Google Scholar
• Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med. 1996;154(3):617–624. doi:10.1164/ajrccm.154.3.8810595
   Web of Science ®Google Scholar
• Ortega M, Almela M, Martinez JA, et al. Epidemiology and outcome of primary community-acquired bacteremia in adult patients. Eur J Clin Microbiol Infect Dis. 2007;26(7):453–457. doi:10.1007/s10096-007-0304-6
   Web of Science ®Google Scholar
• Gradel KO, Jensen US, Schønheyder HC, et al.; For the Danish Collaborative Bacteraemia Network (DACOBAN). Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study. BMC Infect Dis. 2017;17(1):122. doi:10.1186/s12879-017-2233-z
   PubMed Web of Science ®Google Scholar
• Jensen US, Knudsen JD, Wehberg S, Gregson DB, Laupland KB. Risk factors for recurrence and death after bacteraemia: a population-based study. Clin Microbiol Infect. 2011;17(8):1148–1154. doi:10.1111/j.1469-0691.2011.03587.x
   PubMed Web of Science ®Google Scholar
• Sogaard M, Norgaard M, Dethlefsen C, Schonheyder HC. Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis. 2011;52(1):61–69. doi:10.1093/cid/ciq069
   PubMed Web of Science ®Google Scholar
• Nielsen SL, Lassen AT, Kolmos HJ, Jensen TG, Gradel KO, Pedersen C. The daily risk of bacteremia during hospitalization and associated 30-day mortality evaluated in relation to the traditional classification of bacteremia. Am J Infect Control. 2016;44(2):167–172. doi:10.1016/j.ajic.2015.09.011
   Web of Science ®Google Scholar
• Nielsen SL, Lassen AT, Gradel KO, et al. Bacteremia is associated with excess long-term mortality: a 12-year population-based cohort study. J Infect. 2015;70(2):111–126. doi:10.1016/j.jinf.2014.08.012
   PubMed Web of Science ®Google Scholar
• Primo mission 2019. Surveillance of bacterial resistance to antibiotics in community care and in institutions for the elderly dependent. Primo network: 2019 results. Saint-Maurice: Santé publique France; 2021. Available from: www.santepubliquefrance.fr. Accessed December 8, 2022.
   Google Scholar
• Spares mission 2019. Surveillance of antibiotic consumption and bacterial resistance to antibiotics in healthcare institutions. Spares mission: 2019 results. Saint-Maurice: Santé publique France; 2021. Available from: www.santepubliquefrance.fr. Accessed December 8, 2022.
   Google Scholar
• Botelho J, Grosso F, Peixe L. Antibiotic resistance in Pseudomonas aeruginosa – mechanisms, epidemiology and evolution. Drug Resist Updates. 2019;44:100640. doi:10.1016/j.drup.2019.07.002
   PubMed Web of Science ®Google Scholar
• Voor In ‘t Holt AF, Severin JA, Lesaffre EMEH, Vos MC. A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014;58(5):2626–2637. doi:10.1128/AAC.01758-13
   PubMed Web of Science ®Google Scholar
• Nielsen SL. The incidence and prognosis of patients with bacteremia. Dan Med J. 2015;62(7):B5128.
   Web of Science ®Google Scholar
• Friedman ND. Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791. doi:10.7326/0003-4819-137-10-200211190-00007
   PubMed Web of Science ®Google Scholar
• Gradel K, Arpi M, Knudsen J, Schonheyder H, Ostergaard C, Sogaard M. The Danish Collaborative Bacteraemia Network (DACOBAN) database. CLEP. 2014;301. doi:10.2147/CLEP.S66998
   Google Scholar
• Laupland KB, Schønheyder HC, Kennedy KJ, et al. Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative. BMC Res Notes. 2009;2(1):146. doi:10.1186/1756-0500-2-146
   Google Scholar
• Tuppin P, Rudant J, Constantinou P, et al. Value of a national administrative database to guide public decisions: from the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France. Revue d’Épidémiologie et de Santé Publique. 2017;65:S149–S167. doi:10.1016/j.respe.2017.05.004
   PubMed Web of Science ®Google Scholar